Acute Myocardial Infarction Biosensor: A Review From Bottom Up

Area of Science:

• Biomedical Engineering
• Cardiovascular Medicine
• Nanotechnology

Background:

• Acute myocardial infarction (AMI) causes irreversible heart damage due to oxygen deficiency.
• Electrocardiogram (ECG) is insufficient for diagnosis; plasma/saliva biomarker measurement is crucial for AMI prognosis.
• Current biomarker tests are time-consuming and laborious, necessitating improved detection methods.

Purpose of the Study:

• To review key biomarkers and biosensors for acute myocardial infarction (AMI) detection.
• To highlight the role of nanotechnology in developing advanced biosensors for cardiac diagnostics.
• To discuss various biosensor configurations for enhanced AMI biomarker detection.

Main Methods:

• Review of current literature on AMI biomarkers and biosensor technologies.
• Analysis of different biosensor types: Electrical/Electrochemical, Optical, and Mechanical.
• Exploration of nanostructures and nanotechnology applications in biosensor design.

Main Results:

• Biosensors offer enhanced detection of cardiac biomarkers compared to traditional methods.
• Nanotechnology integration significantly improves biosensor sensitivity and efficiency.
• Various nanostructured materials show promise for novel biosensor configurations.

Conclusions:

• Biosensors, particularly those incorporating nanotechnology, represent a significant advancement in AMI diagnosis and prognosis.
• Further research into nanostructured biosensors can overcome limitations of current diagnostic techniques.
• Development of rapid, sensitive, and specific biosensors is critical for timely AMI management.